Abstract
Pyrophosphate ion (PPi) release after nucleotide incorporation is a necessary step for RNA polymerase II (pol II) to enter the next nucleotide addition cycle during transcription elongation. However, the role of pol II residues in PPi release, and the mechanistic relationship between PPi release and the conformational change of the trigger loop remain unclear. In this study, we constructed a Markov State Model (MSM) from extensive all-atom Molecular Dynamics (MD) simulations in the explicit solvent to simulate the PPi release process along the pol II secondary channel. Our results show that the trigger loop has significantly larger intrinsic motion after catalysis and formation of PPi, which in turn, aids PPi release mainly through the hydrogen bonding between the trigger loop residue H1085 and (Mg-PPi)2− group. Once PPi leaves the active site, it adopts a hopping model through several highly conserved positively charged residues such as K752 and K619 to release from the pol II pore region of the secondary channel. These positive hopping sites form favorable interactions with PPi and generate four kinetically meta-stable states as identified by our MSM. Furthermore, our single mutant simulations suggest that H1085 and K752 aid PPi exit from the active site after catalysis, whereas K619 facilitates its passage through the secondary channel. Finally, we suggest that PPi release could help the opening motion of the trigger loop, even though PPi release precedes full opening of the trigger loop due to faster PPi dynamics. Our simulations provide predictions to guide future experimental tests.
Introduction
DNA-dependent RNA polymerases (RNAPs), central cellular machinery in the gene expression process, are responsible for the transcription of DNA into RNA in both prokaryotic and eukaryotic cells1,2. Multi-subunit RNA polymerase II (pol II) in eukaryotic cells plays a unique role in the synthesis of messenger RNA (mRNA), which carries the genetic information from template DNA to protein3–5. In the past decade, an atomic-level view of the transcription mechanism of pol II6–23 and its counterparts in bacteria24–27 has been established.
The nucleotide addition cycle of pol II is a multi-step process3–5,28. In the first step, a nucleotide triphosphate (NTP) is proposed to bind in the addition site (A site) via either an entry site (E site) in the secondary channel10 or a template site in the downstream DNA channel29. Next, a highly conserved domain in pol II, named Trigger Loop (TL), undergoes dramatic structural transition from an open state to a closed state, which can position the incoming NTP and promote the subsequent catalytic reactions13,26,30. Substitutions in or deletion of TL in eukaryotic pol II31 or prokaryotic RNAP26,32,33 can substantially slow the elongation rate. A two-metal ion mechanism has been proposed to catalyze the formation of the phosphodiester bond34,35. In this mechanism, the first Mg2+ ion, termed as metal A, binds independently of NTP and facilitates the nucleophilic attack of the 3′-oxygen from the RNA terminal nucleotide on the α-phosphate of the substrate. The second Mg2+ ion, metal B, is likely to accompany the substrate NTP and product PPi during binding or release. Upon addition of incoming nucleotide to the 3′-RNA chain, PPi is released and the trigger loop switches to the open state. Pol II then translocates one base pair downstream from the pre- to post- translocation register, and is ready for a new cycle of nucleotide addition36,37.
Structural13,26 and genetic studies31,38–42 have shown that several key residues on the TL domain (residues Q1078 to T1095 from Rpb1) of pol II participate in regulating the substrate recognition and catalytic activity. In the recent crystal structure of pol II13, Q1078 is found to interact directly with the 3′-OH group of GTP. L1081 also makes direct contact with the nucleotide base, and mutation of the counterpart residue in E. coli (M932A) can decrease the nucleotide addition rate41. Another highly conserved residue among different species, H1085, is found to interact directly with the phosphate group of NTP13,26. Substitutions of H1085 or its counterparts in both eukaryotic and prokaryotic RNAPs can significantly decrease the rate of the polymerization31,41 as well as the reverse reaction, pyrophosphorolysis42,43. These results suggest that this histidine may make stabilizing contacts in the transition state33,41, or may be directly involved in the catalytic reaction as a proton donor44,45.
After formation of the phosphodiester bond, the product PPi group is thought to release through the secondary channel (or pore) of the pol II46 (see Fig. 1). This channel consists of a narrow pore and a funnel-shaped region. The pore region is surrounded by several discontinuous parts of the Rpb1 and Rpb2 chains of pol II, and also contains the E site10. In addition, several positively charged residues, such as K752, K619, K518 and K620, are located in the pore region. The relationship between the PPi release and translocation is among the least well-understood steps in pol II nucleotide addition cycle. No structure of this state has been obtained. Previous studies47 led to a suggestion that, for the single subunit T7 RNA polymerase, disassociation of the product PPi can induce a protein conformational change that is directly coupled with translocation (called the power-stroke mechanism). In contrast, for multi-subunit RNA polymerases, a Brownian ratchet model48 has been proposed in which the DNA/RNA hybrid can oscillate between the pre- and post- translocation states driven by thermal fluctuations. For multisubunit RNAPs, both single molecular49 and biochemical experiments50 suggest that the PPi release is uncoupled with the translocation process.
Figure 1.

Pyrophosphate ion (PPi) releases through the secondary channel of the pol II. This channel colored in wheat consists of a narrow pore region and a funnel-shaped region. Trigger loop (TL), RNA, template DNA, and non-template DNA are shown in magenta, red, cyan, and green respectively. The PPi is shown as orange sticks, and its bound Mg2+B ion is shown as yellow sphere. Two critical Lysine residues (K752 and K619) along the secondary channel are highlighted in blue.
Although experimental and theoretical studies47–53 have provided a wealth of information for the relationship between the PPi release and structural changes of the polymerase, the atomic level mechanism of PPi release remains a mystery, and no structure of a multisubunit RNAP with bound PPi has been reported. Several important questions remain unanswered. How does PPi release along the secondary channel? What is the role of pol II residues in modulating PPi release? Is PPi release coupled with the opening motion of the TL? To address these questions, we constructed a Markov State Model (MSM) from 122 unbiased 6-ns all-atom molecular dynamics (MD) simulations in the explicit solvent with the system size of ~370,000 atoms. The aggregated simulation time is more than 700 ns. Our results indicate that a few positively charged residues along the secondary channel can facilitate the process of the PPi release by forming “hopping” sites. Within each hopping site, PPi can form favorable interactions with pol II and greatly increase its residence time. Furthermore, we observed a strong coupling between the process of PPi release and the opening motion of the TL.
Methods
1. Setup of the pol II elongation complex
The structure of pol II was modeled from the crystal structure of GTP bound pol II complex (PDB id 2E2H). Missing parts of pol II were added by SWISS pdb software54. More specifically, missing residues 156–160, 186–198, 315–318, 1177–1186, 1232–1235 and 1235–1253 in Rpb1; residues 249–250, 336–344, 438–445, 503–508, 669–677, 715–721, 733–734 and 920–934 in Rpb2; residues 1–2, 49–51, 83–94 and 112–116 in Rpb5; residues 64–75 in Rpb8 were rebuilt. For the longer missing residues, 71–89 and 133–163 in Rpb2 located on the surface of the protein, three residues GAG were applied to replace these two motifs. Other parts in the complex, including the downstream DNA, DNA-RNA hybrid, two Mg2+ ions, eight Zn2+ ions and one GTP, were retained.
GTP bound complex
We have made a small modification on the GTP bound pol II complex structure (PDB id 2E2H) because the O3′ atom of the primer terminal RNA chain is missing in this crystal structure. This leads to the improper coordination modes between the Mg2+A and the oxygen atoms bonded to Pα of the GTP. To add the missing oxygen atom and fix the coordination modes of the Mg2+A, we used the pre-translocation state structure7 (PDB id 1I6H) as the template to refine the structure of 2E2H for the RNA nucleotide at i position, the base, sugar, and monophosphate of GTP, and the metal Mg2+A. After energy minimization, our new model exhibits good binding modes between the GTP and the active site atoms.
PPi bound complex
We modeled the PPi bound pol II complex by breaking the Pα-O bond of GTP in the crystal structure of pol II (PDB id 2E2H) into a PPi molecule and a newly formed nucleotide. For the residue H1085, both protonated and neutral states are considered. Then the two structures were applied to the minimization. Comparison of the minimized structure of PPi bound pol II complex to the crystal structure (2E2H) indicate the minor side chain fluctuations in the active site, suggesting our model is a reasonable starting point (see SI Fig. S1A).
The parameters of the protein residues, DNA, RNA, and ions were taken from the AMBER03 force field55. The parameters of GTP were taken from a previous study56. Since the binding of the Mg2+ to the PPi may induce significant charge transfer, we have regenerated the partial charges of the (Mg-PPi)2− group and its protonated form (Mg-PPiH)1− by RESP fitting to the quantum calculations (HF/6–31G*) using R.E.D. III software57 (see SI Fig. S2).
2. Simulation Details
Molecular Dynamics (MD) simulations
All MD simulations were performed with the GROMACS 4.558. Each protein system was solvated in a cubic box of SPC water molecules59 with the minimum solute-wall box distance of 7.0 Å. 76 Na+ ions were added to neutralize the system. The final PPi bound pol II complex consists of 372,059 atoms. Long-range electrostatic interactions were treated with the Particle-Mesh Ewald (PME) summation method60,61. Van der Waals and short-range electrostatic interactions were cut off at 10 Å. The simulations were run at 310K and 1 bar using the velocity rescaling thermostat and Berendsen barostat respectively62. All chemical bonds were constrained using LINCS algorithm63. We have used a 2 fs time-step and updated the neighbor list every 10 steps. The solvated system was minimized with the steepest decent minimization method followed by a 120 ps simulation with the positions of the protein heavy atoms restrained.
Steered Molecular Dynamics (MD) simulations
Steered MD simulations64 were employed to generate the initial release pathways by pulling the PPi group to three different directions (see SI Fig. S3). One direction is along the wall of the secondary channel choosing the center of mass of the Cα atoms of Rpb1 residues 880–882 and 953–955 as the reference (Ref I). The other two directions are along the central region of the channel pointing to the following two points: (1). The middle point of the center of mass of the Rpb1 residues Asp716-Arg720 and the Ref I, and (2) the middle point of the center of mass of Rpb1 residues Arg726–Arg731 and the Ref I (two gray lines in SI Fig. S3). The external force was applied on the center of mass of the PPi group with the force constant of 0.5 kJ mol−1Å−2 and pulling rate of 0.01Å/ps. For each pulling direction, six independent steered MD simulations were performed starting from different random structures taken from the MD simulations of the PPi bound complex.
Next, we selected the initial conformations from the above steered MD simulations for seeding subsequent unbiased MD simulations. We have clustered the conformations from steered MD simulations into 20 groups using K-center clustering algorithm65. In our clustering method, the geometric distance between a pair of conformations was described by the RMSD value of three PPi atoms (the bridge oxygen and two phosphate atoms), and the pol II conformation was aligned by the bridge helix domain before each RMSD calculation. We then randomly selected roughly the same number of conformations from each cluster (with a total of 122 conformations) to seed unbiased MD simulations.
3. Constructing Markov State Model (MSM)
MSM is a powerful tool for accessing long-timescale dynamics with many short simulations at local equilibrium66–69. MSM partitions phase space into a number of metastable states, such that intra-state transitions are fast but inter-state transitions are slow. This separation of timescales ensures an MSM is Markovian (i.e. that the probability of transitioning from state i to state j depends only on the identity of i and not any previously visited state) and allows MSM built from many short simulations. These dynamics can then be propagated to give global long timescale dynamics:
| (1) |
Where P(nΔt) is a vector of state populations at time nΔt and T is the transition probability matrix.
In order to construct MSM, we first divide 732,000 conformations from the above seeding simulations (122 trajectories, each contains 6000 snapshots) into 274 microstates using the K-center clustering algorithm65. Next we lumped kinetically related microstates into four macrostates using Robust Perron Cluster Cluster Analysis (PCCA+) algorithm70 implemented in the MSMBuilder software65.
We check if the model is Markovian by examining the behaviors of the implied timescales71. Implied timescales (τk) can be calculated as:
| (2) |
Where μk is an eigenvalue of the transition matrix with the lag time τ. Each implied timescale describes an aggregate transition between two subsets of states. If the model is Markovian, the exponentiation of T should be equivalent to an MSM constructed with a longer lag time according to Eq. (1). Under this condition, the implied timescales should be independent of the lag time. The implied timescale plots for both the 274-microstates and 4-macrostates MSM reach the plateau at a lag time from 3 to 4 ns, indicating the model is Markovian (see SI Fig. S4). Thus, we chose a lag time of 3.5 ns to build our model.
The detailed procedure of constructing the MSM is as follows:
3.1. Splitting the conformations into microstates
We first used the k-centers algorithm implemented in MSMBuilder software65 to cluster all the conformations into 300 microstates. We hope that conformations within each microstate are all geometrically similar so that they are also kinetically similar. Indeed, the average distance between conformations of all microstates to their centers is only ~1Å. Here the distance is defined as the RMSD of three atoms of PPi group (the bridge oxygen atom and two phosphate atoms) after aligning the system based on the bridge helix. We then leave out the disconnected or almost disconnected microstates (<30 counts to other states with 1ps lag time), which may due to insufficient sampling or noise. This drops 26 microstates only containing a total of 0.01% of all the conformations. Next, we plotted the implied timescales for the 274-microstate MSM and found that they level off at a lag time from 3 to 4 ns, implying that the model is Markovian (see SI Fig. S4A). Therefore, we further confirm that the microstates are sufficiently small to guarantee that conformations in the same state are kinetically similar.
Calculating Transition Probability Matrix
To calculate a transition probability matrix, we first counted the number of transitions between each pair of states at some interval or lag time to generate a transition count matrix (N). Nij denoted to the number of transitions observed from state i to state j. In this study, we adopted a sliding window of the lag time on each 6ns trajectory with an interval of 1ps between stored conformations to count the transitions. Since the system may quickly go back and forth at the energy barriers, a hard boundary between states may lead to an over-estimation of the number of transitions. We thus adopt a similar procedure as described in Silva et al.66 to eliminate the recrossing events by only counting transitions from state i to state j if the system stayed in state j for at least 300 ps after the transition. Finally, the transition probability matrix was generated by normalizing rows of the transition count matrix.
3.2. Lumping microstate into macrostate
For this system, the implied timescale plots for the 274-microstate MSM display a clear gap in between the third and fourth longest timescales, indicating that there exists four macrostates. We then applied PCCA+ algorithm70,72 implemented in MSMBuilder65 to lump all the microstates into 4 macorstates. The implied timescales were plotted again for the 4-macrostate MSM (see SI Fig. S4B). The results are consistent with the microstate MSMs that all the implied timescale curves level off when the lag time is in between 3ns and 4ns, indicating the model is Markovian. Therefore we select the lag time of 3.5 ns in our further calculation of equilibrium state populations and kinetic properties.
Calculation of the mean first passage time (MFPT)
The MFPT is defined as the average time taken to go from the initial to the final state. As described in ref73. The MFPT from state i to state f (MFPTif) is determined as:
Where Pij is the transition probability from state i to state j, tij is the lag time used to construct the transition probability matrix Tij, and MFPTif is the mean first passage time of the state j to final state f. For each transition, a set of linear equations can be solved under the boundary condition that MFPTff = 0.
Results and Discussion
Formation of the PPi destabilizes the closed conformation of the TL
We first modeled the PPi-bound pol II complex by converting the substrate-bound form of the pol II complex (the GTP-bound and pre-chemistry complex, PDB id 2E2H) into a product-bound complex (PPi-bound and post-chemistry complex) (see Methods). In our model, the TL residue H1085 is protonated and the PPi group is unprotonated (see SI Fig. S5A, and SI text for discussions of the protonation states). The positions of active-site residues in our modeled structure after energy minimization are nearly identical to those in the crystal structure (RMSD <0.8Å, see SI Fig. S1A), indicating our model is a reasonable starting point. In addition, we found that the fluctuations of the TL-tip residues (Rpb1 residues Gln1078 to Ala1087, RMSF=0.78Å) are smaller than those of the whole Rpb1 subunit (RMSF=1.63Å). These results are consistent with the B-factor values in the X-ray structure (PDB ID: 2E2H13), where the average B-factor of the TL-tip residues (~115.15) is lower than that of the Rpb1 subunit (~133.16). Next, we compared the dynamics of the system before (GTP-bound state) and right after chemistry (PPi-bound state) by performing MD simulations. The results show that the TL-tip residues undergo much larger fluctuations at nanosecond timescale in the PPi-bound complex than in the GTP-bound complex (see Fig. 2A).
Figure 2.

These large fluctuations in the PPi-bound complex lead to the breaking of various contacts between the TL and 3′-end of the RNA chain. For example, the interaction between the critical TL residue Q1078 (at which the single substitutions Q1078N or Q1078S are lethal39) with 3′-OH of the substrate is lost (see Fig. 2B). In addition to the TL residues, we also found that other critical interactions between the pol II and 3′-end of RNA chain are lost after the formation of PPi. For example, the critical residue: Rpb1 N479 (its substitution can greatly decrease the elongation rate39) breaks its interaction with the GTP 2′-OH. Other TL residues such as H1085 and F1086 also become more flexible as reflected by significantly larger root mean square fluctuation (RMSF) values after chemistry (see Fig. 2A). These lost or weakened interactions may destablize the interaction network between the 3′-end of the RNA chain and pol II, especially the tip region of the TL. Indeed, at the timescale of several nanoseconds, TL-tip residues already exhibit significantly larger motions than most of enzyme on average (see Fig. 2A). The newly formed PPi also establishes new contacts with pol II residues such as Rpb1 K752. In spite of these newly formed or broken contacts, PPi preserves most of its interactions with pol II in our nanosecond MD simulations, especially with positively charged residues such as Rpb2 R766 and R1020 (see SI Fig. S2). These salt bridge and other interactions can still hold the PPi in the active site, and thus we did not observe any event in which the PPi escapes the active site in our nanosecond MD simulations.
PPi release through the secondary channel pore region occurs via hopping
As discussed in the previous section, nanosecond MD simulations are not able to capture the PPi release due to their insufficient length. In order to overcome this timescale gap, we have applied MSM to model the PPi release at microsecond timescale from shorter nanosecond unbiased MD simulations. MSM has recently shown to be a powerful tool to model long-timescale dynamics from many short MD simulations in protein folding and other conformational changes by us65,66,74,75 and other groups67–69,76,77. In specific, we performed steered MD simulations to generate the initial PPi release pathways using an external force to pull the PPi away from the active site. Next, in order to eliminate the bias of the external force on the release dynamics, we used conformations from these initial pathways as starting points for 122 unbiased 6-ns MD simulations. Finally, data from these short MD simulations were used to build a MSM, which can identify the metastable states, and capture the long-timescale dynamics of PPi release (See SI Fig. S6 and Methods section for details).
We performed 18 steered MD simulations to pull the PPi out of the active site along the secondary channel, which consists of a pore region and a funnel shaped region as shown in Fig. 1. The pore region, surrounded by Rpb1 and Rpb2 domains including the closed TL, is so narrow that it barely allows the PPi to pass through. Because computational simulation of PPi passage through the entire length of the secondary channel is not currently feasible, we focused on PPi release through the pore region, which is likely to be the rate-limiting step for the entire PPi release process. In order to generate multiple alternative initial release pathways, we altered the pulling direction (Methods). In particular, we pulled PPi along three directions from the active site, through the pore, and into the funnel region: one along the wall, and the other two along the central region of the funnel (see SI Fig. S3 for pulling directions). In all the simulations, the Mg2+ B ion is released together with the PPi, even though the pulling force was only applied to PPi. The results also show that the release of the PPi can induce significant conformational changes in the closed state trigger loop and facilitate its transition to the open state. Thus even if the external forces in these steered MD simulations alter the energy landscape, they still provide reasonable initial release pathways for our following studies.
We constructed a 4-state MSM from a total of 122 6-ns unbiased MD simulations derived from the initial release pathways (see Methods section for details of model construction). Based on the results, we propose a hopping model for PPi release, in which the (Mg-PPi)2− ion jumps between three intermediate sites that are composed of positvely charged residues. First, we found two positvely charged residues (Rpb1 K752 and TL H1085) that clamp the (Mg-PPi)2− ion and facilitiate its exit from the active site to the first intermediate state (From state S1 to S2 in Fig. 3B). Next, the (Mg-PPi)2− ion transits from the first to the second intermediate state (From state S2 to S3 in Fig. 3B). During this process, PPi breaks the interactions with K752 and H1085, and forms interactions with another two positively charged residues: Rpb1 K619 and K518. Next, the (Mg-PPi)2− ion can transfer to the fourth metastable state in our simulations in which K620 and K880 form interactions with the (Mg-PPi)2− ion (State S4 in Fig. 3B). The relative equilibrium populations among states S1 to S4 calculated from the MSM are 24.7%, 16.7%, 33.4%, and 25.5%, respectively. PPi is then expected to diffuse into the funnel region of the secondary channel and finally into the solvent. In our simulations of PPi release, we did not observe pol II translocation.
Figure 3.

PPi release pathway through the pore region of the secondary channel identified by Markov State Model (MSM). (A). Four metastable states (S1 to S4) on the releasing pathway are displayed in circles. These pathways contribute 98.2% to the total flux calculated from the transition path theory. Size of these circles is proportional to their equilibrium populations obtained from MSM. (B). The locations of the four states in the channel are displayed with the same color code as in (A). Key interactions between PPi and the pol II in each state is also shown in (B). Several positive residues including K518, K619, K620 and K752 are found to play critical roles in facilitating the PPi release. (C). Multiple sequence alignment of these positively charged residues among different species. The sequence alignment was performed using the online software ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Based on the above analysis, the four positively charged residues: K752, 619, 620 and 518 are likely to play important roles in the PPi release. Although all four residues are well conserved among eukaryotes (from yeast to human, Fig. 3C and SI Fig. S8), only K619 and K752 are conserved among prokaryotes. K620 is altered to Asparagine (N) in T. thermophilus (Fig. 3C), and K518 is altered to the Glutamate (E) in both T. thermophilus and E. coli (Fig. 3C). These results suggest that during the PPi release, K619 and K752 may play common roles in different species, whereas K518 in eukaryotic pol II may have different functions compared with its counterpart residue in bacterial RNAP.
K619 and K752 are located at the previously described non-specific binding site that can be occupied by NTPs (so called “E site”)10. Previous work has predicted that the E site can enhance the rate of NTP diffusion into the pore region of the secondary channel because of the electrostatic attractions between the negatively charged NTP and positively charged E site46. For PPi release, we hypothesize that these positively charged residues in the E site may play a similar role to promote the release of the negatively charged (Mg-PPi)2− ion from the active site. In addition to K619 and K752, the protonated H1085 also contributes to this electrostatic interaction with the (Mg-PPi)2− in our models (see Fig. 3B).
Simulations of pol II mutants reveal individual roles of key residues in facilitating PPi release
Based on our MSM constructed from wild-type (WT) MD smulations, three important residues, H1085, K752 and K619, were identified to be involved in the interactions with PPi during its release from the pore region of the secondary chanel. To elucidate the specific roles of these three residues in different stages of PPi release, we next performed simulations with pol II containing single substitutions.
We designed and simulated several single pol II mutants to examine PPi passage among the different metastable states (see Fig. 4A to C). In particular, we focused on simulations of PPi release for H1085F and K752A (for S1→S2 and S2→S3 transitions), and K619A (for the S2→S3 transition). We chose these substitutions because H1085 and K752 are involved in the interactions with PPi at the S1 and S2 states, whereas K619 is only involved in the interaction with PPi at the S3 state during PPi release (see Fig. 3B). To visualize the selected initial conformations of our simulations, we projected the free energy lanscape of the PPi release onto two reaction coordinates: the distance between the PPi group and the Mg2+A in the active site, and the RMSD value between the PPi conformation and that in the initial modeled PPi-bound complex (see Fig. 4B). This free energy profile also displays four minimums, which are consistent with the four metastable states identified by our MSM.
Figure 4.

Single mutant simulations of three key residues: H1085, K752 and K619 to elucidate their individual roles in the PPi release. (A) The center of mass of the PPi of 100 randomly selected conformations from each metastable state is superimposed. (B) Projection of the PPi free energy landscape on two reaction coordinates: the distance between PPi group and Mg2+A and RMSD of the PPi compared to its bound conformation (see SI Fig. S1A). Mutant simulations are initiated from different points of the energy landscape as shown in black squares. (C) A table summarized the mutant simulations with the elements matching the labels of the simulation results displayed in part (D). (D). Distance as a function of simulation time for different mutant simulations. For simulations starting from S1 (D1 to D3), distance between the PPi group and the Pα atom of the terminal RNA is shown. For simulations starting from the S2 and S3 states (E1 to E3, and SI Fig. S9A and B), distance between PPi group and the Mg2+A is shown. In panels E1 to E3, the four metastable states are highlighted in different colors: S1(gray), S2(light yellow), S3(light blue) and S4(pink).
For the S1→S2 transition, our single variant simulations indicate that residues H1085 and K752 can facilitate this transition and help PPi escape the active site. We use the distance between the Pα atom of the RNA terminal nucleotide and the Pβ atom of the PPi (dαβ) to measure the distance between PPi group and the active site. In the WT simulations, PPi tends to escape the active site with dαβ dramatically increasing from 5.7Å to around 10Å within 5ns in all four simulations (see Fig. 4D1). By losing its interactions with the residue H1085, the PPi group in the H1085F mutant shows much weaker tendency to leave the active site, with dαβ value ending at around 8Å in most simulations (see Fig. 4D2). More strikingly, the PPi group in the K752A mutant becomes even more stable in the active site, with dαβ value at around only 7Å in three out of four simulations (see Fig. 4D3). These results suggest that both H1085 and K752 can help PPi exit the pol II active site and transition from S1 to S2 state.
In sharp contrast, K752 and H1085 play quite different roles in S2→S3 transition. All four 6-ns simulations intiated from S2 in the WT stays in the same S2 state, indicating that S2 is metastable (see Fig. 4E1). Only one of four K752A mutant simulations allows PPi to escape S2, which suggests that the interaction between K752 and the PPi group only plays a minor role in keeping the PPi group in S2 (see Fig. 4E2). However, the H1085F mutant decreases the metastablity of PPi in S2, with three of four simulations further release to the S3. Therefore strong interactions between H1085 and the PPi group can keep it metastable in S2. Further release of the PPi from S2 is coupled with a tip-opening motion of TL in which the sidechain of the H1085 moves away from the closed state. This will eventually disrupt the interactions between PPi and H1085.
We next investigated the role of K619 in PPi movement from S2 to S3 state. With the substitution K619A, two out of four simulations initiated from the S3 but close to the boundary with S2 spend a significant fraction of time back in the state S2 (see SI Fig. S9B). In contrast, none of the simulations initiated from the same four points in the S3 go back to the state S2 in the WT simulations (see SI Fig. S9A). Moreover, one of the WT simulations even reaches the state S4 (the black curve in SI Fig. S9A). Another WT simulation (blue curve in SI Fig. S9A) also samples the region close to the boundary between the S3 and S4. These results clearly show that the positively charged residue K619 facilitates PPi movement from the state S2 to S3, and further transfer to the state S4. Therefore, K619 may serve as the hopping site for the state S3 in our hopping model for PPi. Interestingly, a number of other enzymes employ similar hopping mechanisms for facilitating diffusion across long distances, such as efficient long distance electron translocation within proteins78,79, or searching for target binding site/damage site along the DNA for DNA-binding proteins, restriction enzymes and DNA repair proteins80,81.
PPi release is coupled with the tip motion of the trigger loop, but not with translocation
It has been proposed that release of PPi leads to opening of the TL28,47. However, it is not clear how these two motions are correlated. Does PPi release precede or follow TL opening? Our results suggest that these two motions are highly coupled (see Fig. 5). In particular, the dynamic fluctuations of the TL can help the PPi group to escape the active site, while release of PPi may also be facilitated by the opening motion of the TL. After the catalysis, the large intrinsic motion of the TL promotes movement of PPi from the active site to the first metastable state S2. Specifically, simulations of mutants suggest that the tip part of the trigger loop facilitates PPi to transfer from the S1 to S2 state by the interactions between the TL residue H1085 and PPi (see Fig. 5A and B). Substitution H1085 with Phe tends to trap PPi in the active site.
Figure 5.

Coupling between the trigger loop motion and PPi release. The locations of (Mg-PPi)2− group in A, B and C are same as the S1, S2, S3 in Fig. 3 respectively. And the representation of the pol II is same as in Fig. 2B.
On the other hand, once PPi leaves the active site, its further release can help the opening of the TL by dragging down the TL tip residue H1085 through electrostatic interactions between this residue and the PPi. Without this histidine residue, the PPi group can release much faster in the state S2 (see Fig. 4E). Our results also suggest that PPi release may only aid the early stages of TL opening and that the overall timescale of PPi release is significantly shorter than the timescale for the swinging motion of the TL to a full open state. We draw this conclusion because we did not observe the full open state for the TL in our simulations of PPi release. In particular, the average transition time for PPi along the pore region from the state S1 to S4 is only around 1.5 μs, calculated as mean first passage time (MFPT) from our MSM (see SI Table S1). Importantly, we did not observe any pol II translocation event in our PPi release simulations over this timescale. Averaged pol II elongation rates are typically around one or a few kb min−1. Recently, Maiuri, P et al.82 have discovered a super efficient human pol II system with an elongation rate of ~100 kb min−1 (~600 s/base). Even in this highly efficient system, the time scale of PPi release (~1.5 μs) is still around two orders of magnitude faster than the nucleotide addition. Therefore, the PPi release in pol II is unlikely to be coupled with the translocation step due to the faster dynamics of PPi release. This conclusion is consistent with recent experimental results49,50.
Concluding Remarks and Future Perspectives
This study is focused on the molecular mechanisms of PPi release along the pore segment of the secondary channel in pol II. We discovered four critical metastable states during the PPi release and proposed a hopping model (see Fig. 3 and Fig. 6). Each of the metastable states between S2 and S4 serves as a hopping site with two or three pol II positively charged residues acting as the anchor points to provide favorable interactions with the (Mg-PPi)2−. In particular, three residues: Rpb1 residues K752, K619 and H1085 on the trigger loop, were found to play most important roles during PPi release along the pore region. K752 and K619 residues are located in the entry or E site, previously proposed for NTP loading. Batada et al. shows that loss of the E site can greatly limit the rate of NTP diffusion into the active site, assuming an entry route through the secondary channel46. In this study, we investigated the reverse process, PPi release, and also found these two residues can greatly help the PPi release. Specifically, K752 helps PPi to escape from the active site (state S1 to S2), whereas K619 is involved in the later stage of the release (state S2 to S3). We also discovered that the critical TL residue H1085 can play similar role as K752 to help PPi group escape the active site. Additionally, H1085 serves as a modulation point between the TL and PPi group so that the further release of the PPi helps the opening of the TL tip by dragging down the sidechain of H1085. These transient interactions of the TL with PPi in its distinct hopping sites could play a key role in guiding the TL to unfold without becoming trapped in conformations or by interactions that could potentially slow transcription. Our results also suggest that the PPi release occurs before full opening of TL due to the faster dynamics of PPi. Thus, our results suggest PPi release is not coupled with translocation.
Figure 6.

Cartoon model of PPi release and its couplings with the opening of the trigger loop.
Site-directed mutagenesis experiments can be designed to test key predictions of our computational results. For example, substitutions of K752 and K619 to hydrophobic/acidic residues may disrupt the positively charged pocket identified from our simulations and slow down the rate for both PPi release and the reverse process, NTP addition. Alternatively, changes such as increasing the positive charges in hopping sites may be able to trap stable intermediate states during the PPi release. Finally, chemical cross-linking between the trigger loop and pol II may also help trap the state with the TL closed while PPi still occupies the active site.
It will also be of interest to compare the PPi-release mechanisms between eukaryotic and prokaryotic RNA polymerases. Crystal structures of the RNAP from T. thermophilus shows that the secondary channels in the eukaryote and prokaryote are quite different26. Specifically the secondary channel of the bacterial RNAP is shorter compared to the yeast channel, which may lead to faster PPi release. Morever, the bacterial RNAP contains an extra positively charged TL residue, R1239 in T. thermophilus (R933 in E. coli) in addition to the H1242 (H936 in E. coli). Mutagenesis studies have shown that changing this Arginine to Alanine decreases the elongation rate41. Another striking difference between the bacterial and yeast RNA polymerase is that the positively charged residue K518 in yeast is replaced with a negatively charged residue E776 in T. thermophilus or E497 in E. coli (see Fig. 3C). This change in the pore region of the secondary channel may also lead to different mechanisms for PPi release in eukaryotic and prokaryotic RNA polymerases.
Supplementary Material
ACKNOWLEDGEMENT
X.H. acknowledges Hong Kong Research Grants Council (661011, DAG11SC02G, and HKUST6/CRF/10). D.W. acknowledges the NIH (GM085136), start-up funds from Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD and Academic Senate Research Award from UCSD. Computing resources were provided by the CCB computer cluster in HKUST and Dawning TC5000 supercomputing cluster in Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. We thank Dr. Robert Landick for his extensive critical reading of the manuscript.
Footnotes
Supporting Information. Discussions about the protonation states of PPi and the TL residue H1085 after the catalysis (Text and Fig. S1, S5 and S7). RESP charges for fitting the force field of (Mg-PPi)2− group and its protonated form (Mg-PPiH)1− (Fig. S2). Three pulling directions in the steered MD simulations (Fig. S3). Implied timescales plots of MSMs (Fig. S4). Flowchart of our simulation methodology (Fig. S6). Comparisons of the location of three conserved residues in the secondary channel of the yeast RNA pol II and bacterial RNAP (Fig. S8). Mutation simulation results to elucidate the role of Rpb1 residue K619 on PPi release (Fig. S9) and MFPT results (Table S1). This material is available free of charge via the Internet at http://pubs.acs.org.
References
- (1).Lee TI, Young RA. Annu. Rev. Genet. 2000;34:77–137. doi: 10.1146/annurev.genet.34.1.77. [DOI] [PubMed] [Google Scholar]
- (2).Hurwitz J. J. Biol. Chem. 2005;280:42477–42485. doi: 10.1074/jbc.X500006200. [DOI] [PubMed] [Google Scholar]
- (3).Shilatifard A, Conaway RC, Conaway JW. Annu. Rev. Biochem. 2003;72:693–715. doi: 10.1146/annurev.biochem.72.121801.161551. [DOI] [PubMed] [Google Scholar]
- (4).Fuda NJ, Ardehali MB, Lis JT. Nature. 2009;461:186–192. doi: 10.1038/nature08449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).Kornberg RD. Proc. Natl. Acad. Sci. U.S.A. 2007;104:12955–12961. doi: 10.1073/pnas.0704138104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).Cramer P, Bushnell DA, Fu J, Gnatt AL, Maier-Davis B, Thompson NE, Burgess RR, Edwards AM, David PR, Kornberg RD. Science. 2000;288:640–649. doi: 10.1126/science.288.5466.640. [DOI] [PubMed] [Google Scholar]
- (7).Cramer P, Bushnell DA, Kornberg RD. Science. 2001;292:1863–1876. doi: 10.1126/science.1059493. [DOI] [PubMed] [Google Scholar]
- (8).Gnatt AL, Cramer P, Fu J, Bushnell DA, Kornberg RD. Science. 2001;292:1876–1882. doi: 10.1126/science.1059495. [DOI] [PubMed] [Google Scholar]
- (9).Kettenberger H, Armache KJ, Cramer P. Mol. Cell. 2004;16:955–965. doi: 10.1016/j.molcel.2004.11.040. [DOI] [PubMed] [Google Scholar]
- (10).Westover KD, Bushnell DA, Kornberg RD. Cell. 2004;119:481–489. doi: 10.1016/j.cell.2004.10.016. [DOI] [PubMed] [Google Scholar]
- (11).Westover KD, Bushnell DA, Kornberg RD. Science. 2004;303:1014–1016. doi: 10.1126/science.1090839. [DOI] [PubMed] [Google Scholar]
- (12).Temiakov D, Zenkin N, Vassylyeva MN, Perederina A, Tahirov TH, Kashkina E, Savkina M, Zorov S, Nikiforov V, Igarashi N. Mol. Cell. 2005;19:655–666. doi: 10.1016/j.molcel.2005.07.020. [DOI] [PubMed] [Google Scholar]
- (13).Wang D, Bushnell DA, Westover KD, Kaplan CD, Kornberg RD. Cell. 2006;127:941–954. doi: 10.1016/j.cell.2006.11.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Brueckner F, Hennecke U, Carell T, Cramer P. Science. 2007;315:859–862. doi: 10.1126/science.1135400. [DOI] [PubMed] [Google Scholar]
- (15).Brueckner F, Cramer P. Nat. Struct. Mol. Biol. 2008;15:811–818. doi: 10.1038/nsmb.1458. [DOI] [PubMed] [Google Scholar]
- (16).Damsma GE, Cramer P. J. Biol. Chem. 2009;284:31658–31663. doi: 10.1074/jbc.M109.022764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).Kostrewa D, Zeller ME, Armache KJ, Seizl M, Leike K, Thomm M, Cramer P. Nature. 2009;462:323–330. doi: 10.1038/nature08548. [DOI] [PubMed] [Google Scholar]
- (18).Sydow JF, Brueckner F, Cheung A, Damsma GE, Dengl S, Lehmann E, Vassylyev D, Cramer P. Mol. Cell. 2009;34:710–721. doi: 10.1016/j.molcel.2009.06.002. [DOI] [PubMed] [Google Scholar]
- (19).Sydow JF, Cramer P. Curr. Opin. Struc. Biol. 2009;19:732–739. doi: 10.1016/j.sbi.2009.10.009. [DOI] [PubMed] [Google Scholar]
- (20).Wang D, Bushnell DA, Huang X, Westover KD, Levitt M, Kornberg RD. Science. 2009;324:1203–1206. doi: 10.1126/science.1168729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (21).Liu X, Bushnell DA, Wang D, Calero G, Kornberg RD. Science. 2010;327:206–209. doi: 10.1126/science.1182015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).Wang D, Zhu G, Huang X, Lippard SJ. Proc. Natl. Acad. Sci. U.S.A. 2010;107:9584–9589. doi: 10.1073/pnas.1002565107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (23).Cheung ACM, Cramer P. Nature. 2011;471:249–253. doi: 10.1038/nature09785. [DOI] [PubMed] [Google Scholar]
- (24).Vassylyev DG, Sekine S, Laptenko O, Lee J, Vassylyeva MN, Borukhov S, Yokoyama S. Nature. 2002;417:712–719. doi: 10.1038/nature752. [DOI] [PubMed] [Google Scholar]
- (25).Vassylyev DG, Vassylyeva MN, Perederina A, Tahirov TH, Artsimovitch I. Nature. 2007;448:157–162. doi: 10.1038/nature05932. [DOI] [PubMed] [Google Scholar]
- (26).Vassylyev DG, Vassylyeva MN, Zhang J, Palangat M, Artsimovitch I, Landick R. Nature. 2007;448:163–168. doi: 10.1038/nature05931. [DOI] [PubMed] [Google Scholar]
- (27).Tagami S, Sekine S, Kumarevel T, Hino N, Murayama Y, Kamegamori S, Yamamoto M, Sakamoto K, Yokoyama S. Nature. 2010;468:978–982. doi: 10.1038/nature09573. [DOI] [PubMed] [Google Scholar]
- (28).Brueckner F, Ortiz J, Cramer P. Curr. Opin. Struc. Biol. 2009;19:294–299. doi: 10.1016/j.sbi.2009.04.005. [DOI] [PubMed] [Google Scholar]
- (29).Nedialkov YA, Gong XQ, Hovde SL, Yamaguchi Y, Handa H, Geiger JH, Yan H, Burton ZF. J. Biol. Chem. 2003;278:18303–18312. doi: 10.1074/jbc.M301103200. [DOI] [PubMed] [Google Scholar]
- (30).Huang X, Wang D, Weiss DR, Bushnell DA, Kornberg RD, Levitt M. Proc. Natl. Acad. Sci. U.S.A. 2010;107:15745–15750. doi: 10.1073/pnas.1009898107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (31).Kaplan CD, Larsson KM, Kornberg RD. Mol. Cell. 2008;30:547–556. doi: 10.1016/j.molcel.2008.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (32).Toulokhonov I, Zhang J, Palangat M, Landick R. Mol. Cell. 2007;27:406–419. doi: 10.1016/j.molcel.2007.06.008. [DOI] [PubMed] [Google Scholar]
- (33).Yulia Y, Aleksandra B, Vasisht T, Mohammad R, Savva Z, Konstantin S, Nikolay Z. BMC. Biol. 2010;8:54–69. [Google Scholar]
- (34).Sosunov V, Sosunova E, Mustaev A, Bass I, Nikiforov V, Goldfarb A. EMBO. J. 2003;22:2234–2244. doi: 10.1093/emboj/cdg193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (35).Yang W, Lee JY, Nowotny M. Mol. Cell. 2006;22:5–13. doi: 10.1016/j.molcel.2006.03.013. [DOI] [PubMed] [Google Scholar]
- (36).Svetlov V, Nudler E. Curr. Opin. Struc. Biol. 2009;19:701–707. doi: 10.1016/j.sbi.2009.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (37).Feig M, Burton ZF. Biophys. J. 2010;99:2577–2586. doi: 10.1016/j.bpj.2010.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (38).Svetlov V, Vassylyev DG, Artsimovitch I. J. Biol. Chem. 2004;279:38087–38090. doi: 10.1074/jbc.C400316200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (39).Trinh V, Langelier MF, Archambault J, Coulombe B. Microbiol. Mol. Biol. R. 2006;70:12–36. doi: 10.1128/MMBR.70.1.12-36.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (40).Tan L, Wiesler S, Trzaska D, Carney HC, Weinzierl ROJ. J. Biol. 2008;7:40–54. doi: 10.1186/jbiol98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (41).Zhang J, Palangat M, Landick R. Nat. Struct. Mol. Biol. 2009;17:99–104. doi: 10.1038/nsmb.1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (42).Yuzenkova Y, Zenkin N. Proc. Natl. Acad. Sci. U.S.A. 2010;107:10878–10883. doi: 10.1073/pnas.0914424107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (43).Zenkin N, Yuzenkova Y, Severinov K. Science. 2006;313:518–520. doi: 10.1126/science.1127422. [DOI] [PubMed] [Google Scholar]
- (44).Castro C, Smidansky E, Maksimchuk KR, Arnold JJ, Korneeva VS, Gotte M, Konigsberg W, Cameron CE. Proc. Natl. Acad. Sci. U.S.A. 2007;104:4267–4272. doi: 10.1073/pnas.0608952104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (45).Castro C, Smidansky ED, Arnold JJ, Maksimchuk KR, Moustafa I, Uchida A, G tte M, Konigsberg W, Cameron CE. Nat. Struct. Mol. Biol. 2009;16:212–218. doi: 10.1038/nsmb.1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (46).Batada NN, Westover KD, Bushnell DA, Levitt M, Kornberg RD. Proc. Natl. Acad. Sci. U.S.A. 2004;101:17361–17364. doi: 10.1073/pnas.0408168101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (47).Yin YW, Steitz TA. Cell. 2004;116:393–404. doi: 10.1016/s0092-8674(04)00120-5. [DOI] [PubMed] [Google Scholar]
- (48).Bar-Nahum G, Epshtein V, Ruckenstein AE, Rafikov R, Mustaev A, Nudler E. Cell. 2005;120:183–193. doi: 10.1016/j.cell.2004.11.045. [DOI] [PubMed] [Google Scholar]
- (49).Abbondanzieri EA, Greenleaf WJ, Shaevitz JW, Landick R, Block SM. Nature. 2005;438:460–465. doi: 10.1038/nature04268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (50).Hein PP, Palangat M, Landick R. Biochemistry. 2011;50:7002–7014. doi: 10.1021/bi200437q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (51).Guajardo R, Sousa R. J. Mol. Biol. 1997;265:8–19. doi: 10.1006/jmbi.1996.0707. [DOI] [PubMed] [Google Scholar]
- (52).Xiong Y, Burton ZF. J. Biol. Chem. 2007;282:36582–36592. doi: 10.1074/jbc.M707014200. [DOI] [PubMed] [Google Scholar]
- (53).Golosov AA, Warren JJ, Beese LS, Karplus M. Structure. 2010;18:83–93. doi: 10.1016/j.str.2009.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (54).Schwede T, Kopp J, Guex N, Peitsch MC. Nucleic. Acids. Res. 2003;31:3381–3385. doi: 10.1093/nar/gkg520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (55).Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T. J. Comput. Chem. 2003;24:1999–2012. doi: 10.1002/jcc.10349. [DOI] [PubMed] [Google Scholar]
- (56).Meagher KL, Redman LT, Carlson HA. J. Comput. Chem. 2003;24:1016–1025. doi: 10.1002/jcc.10262. [DOI] [PubMed] [Google Scholar]
- (57).Dupradeau FY, Pigache A, Zaffran T, Savineau C, Lelong R, Grivel N, Lelong D, Rosanski W, Cieplak P. Phys. Chem. Chem. Phys. 2010;12:7821–7839. doi: 10.1039/c0cp00111b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (58).Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. J. Comput. Chem. 2005;26:1701–1718. doi: 10.1002/jcc.20291. [DOI] [PubMed] [Google Scholar]
- (59).Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J. Interaction models for water in relation to protein hydration. In: Pullman B, editor. Intermolecular forces. Reidel Publishing Company; Dordrecht: 1981. [Google Scholar]
- (60).Darden T, York D, Pedersen L. J. Chem. Phys. 1993;98:10089–10092. [Google Scholar]
- (61).Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. J. Chem. Phys. 1995;103:8577–8593. [Google Scholar]
- (62).Berendsen HJC, Postma JPM, Van Gunsteren WF, DiNola A, Haak J. J. Chem. Phys. 1984;81:3684–3690. [Google Scholar]
- (63).Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. J. Comput. Chem. 1997;18:1463–1472. [Google Scholar]
- (64).Isralewitz B, Gao M, Schulten K. Curr. Opin. Struc. Biol. 2001;11:224–230. doi: 10.1016/s0959-440x(00)00194-9. [DOI] [PubMed] [Google Scholar]
- (65).Bowman GR, Huang X, Pande VS. Methods. 2009;49:197–201. doi: 10.1016/j.ymeth.2009.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (66).Silva DA, Bowman GR, Sosa-Peinado A, Huang X. PLoS. Comput. Biol. 2011;7:e1002054. doi: 10.1371/journal.pcbi.1002054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (67).Bowman GR, Voelz VA, Pande VS. Curr. Opin. Struc. Biol. 2010;21:4–11. doi: 10.1016/j.sbi.2010.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (68).Noé F, Fischer S. Curr. Opin. Struc. Biol. 2008;18:154–162. doi: 10.1016/j.sbi.2008.01.008. [DOI] [PubMed] [Google Scholar]
- (69).Chodera JD, Singhal N, Pande VS, Dill KA, Swope WC. J. Chem. Phys. 2007;126:155101–155117. doi: 10.1063/1.2714538. [DOI] [PubMed] [Google Scholar]
- (70).Deuflhard P, Weber M. Linear. Algebra. Appl. 2005;398:161–184. [Google Scholar]
- (71).Swope WC, Pitera JW, Suits F. J. Phys. Chem. B. 2004;108:6571–6581. [Google Scholar]
- (72).Deuflhard P, Huisinga W, Fischer A, Schütte C. Linear. Algebra. Appl. 2000;315:39–59. [Google Scholar]
- (73).Singhal N, Snow CD, Pande VS. J. Chem. Phys. 2004;121:415–425. doi: 10.1063/1.1738647. [DOI] [PubMed] [Google Scholar]
- (74).Huang X, Bowman GR, Bacallado S, Pande VS. Proc. Natl. Acad. Sci. U.S.A. 2009;106:19765–19769. doi: 10.1073/pnas.0909088106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (75).Zhuang W, Cui RZ, Silva DA, Huang X. J. Phys. Chem. B. 2011;115:5415–5424. doi: 10.1021/jp109592b. [DOI] [PubMed] [Google Scholar]
- (76).Swope WC, Pitera JW, Suits F. The J. Phys. Chem. B. 2004;108:6571–6581. [Google Scholar]
- (77).Sriraman S, Kevrekidis IG, Hummer G. J. Phys. Chem. B. 2005;109:6479–6484. doi: 10.1021/jp046448u. [DOI] [PubMed] [Google Scholar]
- (78).Giese B, Graber M, Cordes M. Curr. Opin. Chem. Biol. 2008;12:755–759. doi: 10.1016/j.cbpa.2008.08.026. [DOI] [PubMed] [Google Scholar]
- (79).Gray HB, Winkler JR. Biochimica et Biophysica Acta (BBA)-Bioenergetics. 2010;1797:1563–1572. doi: 10.1016/j.bbabio.2010.05.001. [DOI] [PubMed] [Google Scholar]
- (80).Halford SE, Marko JF. Nucleic. Acids. Res. 2004;32:3040–3052. doi: 10.1093/nar/gkh624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (81).Friedman JI, Stivers JT. Biochemistry. 2010;49:4957–4967. doi: 10.1021/bi100593a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (82).Maiuri P, Knezevich A, De Marco A, Mazza D, Kula A, McNally JG, Marcello A. EMBO Rep. 2011;12:1280–2185. doi: 10.1038/embor.2011.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
